PER 6.25% 6.8¢ percheron therapeutics limited

Kosenarim happy to explain my earlier post to youMost on here...

  1. 12,759 Posts.
    lightbulb Created with Sketch. 1285
    Kosenar

    im happy to explain my earlier post to you
    Most on here didn’t understand what I meant.
    ok
    We are trading at 8,3c
    and we continue to trade at 8.3 c until Nov 24 when the results of
    the Tox study and the 6 month read out occur…
    If we are successful in both studies
    The sp should be $1.20
    A phase 3 molecule is worth $1.20 a PER share
    My point being
    Does it really matter if our Sp is 8.3c now
    35c in Sept 24…
    Are you a seller?
    So it does not matter if you believe in Atl1102 being a block buster drug…the end game is $1.20 by years end..
    Now
    If you don’t believe in Atl1102 and scared that the drug will fail on both counts.. then you will be in panic mode wanting the current sp to go up so you can SELL..and make a mediocre profit.
    Conclusion: If your a long term holder and want dividends and the sp to go up greater than 500 times ( my previous post re Cochlear) then the current sp matters not..
    That’s the point I’m making

    Can anyone explain what I’m saying better.. to the people who are genuinely interested..


    Now to your question
    The 15 c prediction was that registration was completed in March 24
    But
    I did warn people that delays could push it to the second week in April…
    So I’m still predicting 15c if the registration comes in the first or second week in April
    Happy Easter








 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
6.8¢
Change
0.004(6.25%)
Mkt cap ! $61.30M
Open High Low Value Volume
6.6¢ 7.1¢ 6.5¢ $198.2K 2.885M

Buyers (Bids)

No. Vol. Price($)
1 14845 6.8¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 10000 1
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
6.8¢
  Change
0.004 ( 14.3 %)
Open High Low Volume
6.6¢ 7.1¢ 6.6¢ 295714
Last updated 15.58pm 26/04/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.